Advertisement

Regulatory Mechanisms of Thrombomodulin Expression in the Human Umbilical Vein Endothelial Cells

  • S. Ohdama
  • S. Takano
  • S. Miyake
  • K. Hirokawa
  • N. Aoki
Conference paper

Abstract

Thrombomodulin (TM) is a cell surface glycoprotein that plays an important role in inhibition of intravascular coagulation as a cofactor for the thrombin-catalyzed activation of protein C.1 It contributes to thromboresistant properties of endothelium. We reported that TM-fragments increased in plasma of patients with various thrombotic disorders such as DIC, ARDS and pulmonary thromboembolism.2 However, it is not clear whether the increase of TM-fragments in plasma is caused simply by vascular damages or reflects an increase of expression of TM in endothelial cells. In this paper, we summarize our studies on the regulatory mechanisms of TM expression in vitro assuming its role in pathogenesis of hypercoagulable states.

Keywords

Human Umbilical Vein Endothelial Cell Phorbol Myristate Acetate Phorbol Myristate Acetate Cesium Chloride Thrombotic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Refferences

  1. 1.
    Esmon C.T. and Owen W.G. (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Pro. Natl. Acad. Sci. U.S.A. 78:2249–2252.CrossRefGoogle Scholar
  2. 2.
    Takano S., Kimura S., Ohdama S. and Aoki N. (1990) Plasma thrombomodulin in health and diseases. Blood 76:2024–2029.PubMedGoogle Scholar
  3. 3.
    Kimura S., Nagoya T. and Aoki N. (1989) Monoclonal antibodies to human thrombomodulin whose binding is calcium dependent. J. Biochem. 105:478–483.PubMedGoogle Scholar
  4. 4.
    Hirokawa K. and Aoki N. (1990) Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vivo. J. Biochem. 108:839–845.PubMedGoogle Scholar
  5. 5.
    Nawroth P.P. and Stern D.M. (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163:740–745.PubMedCrossRefGoogle Scholar
  6. 6.
    Conway E.M. and Rosenberg R.D. (1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell. Biol. 8:5588–5592.PubMedGoogle Scholar
  7. 7.
    Nawroth P.P., Handley D.A., Esmon C.T. and Stern D.M. (1986) Interleukin 1 induces endothelial cell procoagulant while suppresssing cell-surface anticoagulant activity. Proc. Natl. Acad. Sci. U.S.A. 83: 3460–3464.PubMedCrossRefGoogle Scholar
  8. 8.
    Moore K.L., Andreoli S.P., Esmon N.L., Esmon C.T. and Bang N.U. (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79:124–130.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohdama S., Takano S., Miyake S. and Aoki N.(1991) Pentoxifylline prevents tumor necrosis factor induced suppression of endothelial cell surface thrombomodulin. Thromb. Res. 62: 745–755.PubMedCrossRefGoogle Scholar
  10. 10.
    Hirokawa K. and Aoki N. (1991) Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J. Cell. Physiol. 147:157–165.PubMedCrossRefGoogle Scholar
  11. 11.
    Hirokawa K. and Aoki N. (1991) Up-regulation of thrombomodulin by activation of histamine Hi-receptors in human umbilical vein endothelial cells in vitro. Biochem. J. 276:739–743.PubMedGoogle Scholar
  12. 12.
    Ohdama S. and Aoki N. in preparation.Google Scholar

Copyright information

© Springer Japan 1992

Authors and Affiliations

  • S. Ohdama
    • 1
  • S. Takano
    • 1
  • S. Miyake
    • 1
  • K. Hirokawa
    • 1
  • N. Aoki
    • 1
  1. 1.The First Department of Internal MedicineTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations